Track topics on Twitter Track topics that are important to you
Monitoring hydroxychloroquine levels in patients with systemic lupus erythematosus allowed physicians to identify noncompliance and made dose titration easier. In this longitudinal study, researchers followed 276 patients with systemic lupus erythematosus (SLE) who were treated with hydroxychloroquine (HCQ) in the rheumatology clinics of Tuen Mun Hospital in Hong Kong during a 9-month period starting in 2011. For inclusion in the study, patients had to be at least 18 years old, fulfill four or more of the 1997 American College of Rheumatology classification criteria for SLE and have been taking HCQ for at least 6 months.
Original Article: Therapeutic HCQ levels associated with fewer SLE flaresNEXT ARTICLE
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...
Lupus is a complex and poorly understood condition that affects many parts of the body and causes symptoms ranging from mild to life-threatening. There are several types of lupus. The main types are: discoid lupus erythematosus drug-induced lu...